News) announced Tuesday that it has entered into an agreement with Accelsiors CRO & Consultancy Services, a clinical research organization with experience in conducting multiple sclerosis trials, to oversee the 200-patient Phase II trial of NeuroVax, an investigational T-cell receptor, or TCR, peptide vaccine for the treatment of MS."> News) announced Tuesday that it has entered into an agreement with Accelsiors CRO & Consultancy Services, a clinical research organization with experience in conducting multiple sclerosis trials, to oversee the 200-patient Phase II trial of NeuroVax, an investigational T-cell receptor, or TCR, peptide vaccine for the treatment of MS."> News) announced Tuesday that it has entered into an agreement with Accelsiors CRO & Consultancy Services, a clinical research organization with experience in conducting multiple sclerosis trials, to oversee the 200-patient Phase II trial of NeuroVax, an investigational T-cell receptor, or TCR, peptide vaccine for the treatment of MS."> News) announced Tuesday that it has entered into an agreement with Accelsiors CRO & Consultancy Services, a clinical research organization with experience in conducting multiple sclerosis trials, to oversee the 200-patient Phase II trial of NeuroVax, an investigational T-cell receptor, or TCR, peptide vaccine for the treatment of MS.">
|
The San Diego Daily Transcript is San Diego’s only information company offering business news, data and resources daily and hourly. We report on San Diego business, finance and the San Diego economy, real estate, construction, the U.S. military in San Diego, and San Diego government construction bids.
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
![]() |
| All contents herein copyright San Diego Source | The Daily Transcript ® 1994-2009 |